Clinical Efficacy Evaluation of a Continuous Glucose Monitoring-Guided Forecasting Algorithm to Mitigate Postbariatric Hypoglycemia: A Randomized Controlled Trial

Résumé fourni par la source

Postbariatric hypoglycemia (PBH) after Roux-en-Y gastric bypass predisposes to health risks and impaired quality of life. Given limited therapeutic options, we evaluated the efficacy of a continuous glucose monitoring (CGM)-guided forecasting algorithm to reduce PBH. In this randomized trial, 59 participants underwent a standardized meal test and were assigned to receive 5 g of glucose either upon the algorithm’s predictive alert (intervention, n = 32) or when plasma glucose declined below 3.0 mmol/L (control, n = 27). Hypoglycemia incidence (<3.0 mmol/L) was 31% in the intervention group and 44% in the control group ( P = 0.30). Nadir glucose and time spent below 3.9 and 3.0 mmol/L did not differ significantly between groups. Extrapolation based on previously published glucose dose–response data suggests that increasing the preventive glucose dose to 10 g could reduce hypoglycemia incidence to 9%. While a 5 g preventive dose was insufficient, these simulations indicate that CGM-guided hypoglycemia forecasting warrants evaluation as an approach for reducing postprandial hypoglycemia in individuals with PBH.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.